A multi-country study led by IVI in partnership with BBIL, funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology, India starts clinical trial on chikungunya vaccine.
from Medindia Health News https://ift.tt/3Bai00H
No comments:
Post a Comment